Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES ATRIA IN CONNECTION WITH SALE OF FALBYGDENS OST
Mandate

VINGE ADVISES ATRIA IN CONNECTION WITH SALE OF FALBYGDENS OST

October 16, 2014

Vinge has advised Atria Sverige in connection with the sale of Falbygdens Ost to Arla Foods. Falbygdens Ost does not have its own cheese production facilities but, rather, buys cheese from other producers. Falbygdens Ost has approximately 100 employees and a turnover of approximately SEK 470 million. The transaction is subject to approval by the Swedish Competition Authority.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Alex Miler, Daniel Unger and Malin Buch as well as project assistant Josefin Backlund. Partner Johan Karlsson and associate Emil Fahlén Godö provided competition law advice.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025